Álvarez, Diana and Levine, Melanie and Rojas, Mauricio (2014) Mesenchymal stem cells for therapy in lung diseases. Shortness of Breath, 3 (2). pp. 51-57. ISSN 2281-6550
|
Text
article.pdf - Published Version Download (626kB) | Preview |
Abstract
Lung diseases are among the most devastating illnesses because of their prevalence and simultaneous lack of viable treatment. To advance beyond the current options of mechanical ventilation and trans-plantation, research in recent years has focused on cell therapy, and of the possibilities, mesenchymal stem cells (MSCs) are the most promising. MSCs have immunomodulatory and secretory effects that work to relieve inflammation and prevent fibrosis in response to the injured lung. Numerous small and large animal models have shown the ameliorating effects of MSCs in diseases such as idiopathic pulmonary fibrosis, chronic obstructive pulmonary disorder, acute respiratory distress syndrome, obstructive sleep apnea, bronchiolitis obliterans, and asthma. Clinical trials for MSC use in some of these are in their early stages, but the encouraging promise of this cell therapy will ensure more trials to come. This review will first discuss MSCs as a population with varied properties and mechanisms of action and then will examine the efforts so far to use MSCs as treatment in various lung diseases.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | mesenchymal stem cells, lung disease, cell therapy, aging, clinical trials |
Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) |
Depositing User: | Marina Spanti |
Date Deposited: | 21 Jan 2016 17:54 |
Last Modified: | 21 Jan 2016 17:54 |
URI: | http://eprints.bice.rm.cnr.it/id/eprint/10507 |
Actions (login required)
View Item |